| Product NDC: | 50242-134 |
| Proprietary Name: | Herceptin |
| Non Proprietary Name: | Trastuzumab |
| Active Ingredient(s): | & nbsp; Trastuzumab |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50242-134 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103792 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19980925 |
| Package NDC: | 50242-134-68 |
| Package Description: | 1 KIT in 1 CARTON (50242-134-68) * 20 mL in 1 VIAL, MULTI-DOSE * 20 mL in 1 VIAL |
| NDC Code | 50242-134-68 |
| Proprietary Name | Herceptin |
| Package Description | 1 KIT in 1 CARTON (50242-134-68) * 20 mL in 1 VIAL, MULTI-DOSE * 20 mL in 1 VIAL |
| Product NDC | 50242-134 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Trastuzumab |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 19980925 |
| Marketing Category Name | BLA |
| Labeler Name | Genentech, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |